Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

JO 1784

Known as: JO-1784 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
1. Sigma receptors were first described in 1976 as opiate receptors but were later determined to be a distinct class of receptors… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
We have previously shown in vivo that low doses of selective sigma (sigma) receptor ligands potentiate selectively and dose… Expand
Is this relevant?
1996
1996
Recently much research interest has focused on the possible therapeutic uses of sigma-receptor ligands in psychiatric and… Expand
Is this relevant?
1996
1996
The immobility time in the mouse forced swimming test was dose-dependently reduced by sigma 1 receptor agonists, such as 1-(3,4… Expand
Is this relevant?
1996
1996
Middle cerebral artery occlusion (MCAO) is a widely used surgical procedure for inducing focal cortical ischaemia in mice. In the… Expand
Is this relevant?
1995
1995
To assess the effects of the novel sigma receptor ligand JO 1784 ((+)-N-cyclopropyl-methyl-N-methyl-1,4-diphenyl-1-yl-but-3-en-1… Expand
Is this relevant?
1992
1992
We have reported previously that the high affinity sigma ligand DTG potentiates N-methyl-D-aspartate (NMDA)-induced excitation of… Expand
Is this relevant?
1992
1992
The effects of neuropeptide Y (NPY), sigma ligand (JO 1784) and sulfated cholecystokinin octapeptide (CCK8s) on emotional stress… Expand
Is this relevant?
1992
1992
SummaryThe effects of the high affinity sigma (σ) ligands 1,3-di(2-tolyl)guanidine (DTG), (+)N-cyclopropylmethyl-N-methyl-1,4… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1991
1991
JO 1784 ((+)-N-Cyclopropyl-methyl-N-methyl-1,4-diphenyl-1-yl-but-3-en-1-ylami ne, hydrochloride), has been recently described as… Expand
Is this relevant?